Literature DB >> 10548213

Effect of growth hormone therapy in mitigating hypoxia-induced and food restriction-induced growth retardation in the newborn rat.

D Y Moromisato1, M Y Moromisato, J A Brasel, D M Cooper.   

Abstract

OBJECTIVE: Hypoxia may alter the neuroendocrine control of catabolic and anabolic states early in postnatal life by modulating the growth hormone-insulin-like growth factor-I (GH-IGF-I) system. We wondered: a) to what extent hypoxia effects on the GH-IGF-I axis differed from those of food deprivation alone; and b) whether administration of exogenous GH mitigates alterations of the GH-IGF-I axis caused by hypoxia or food restriction.
DESIGN: Prospective laboratory investigation using nursing dams and suckling pups. Experimental groups included: a) room air control subjects; b) hypoxia-exposed subjects (FIO2, 0.12); or c) room air breathing subjects whose dam food intake was matched to that of hypoxic dams. Half of the pups in each group were administered rat GH (100 microg subcutaneously each day), and the remaining received vehicle alone. The intervention lasted 18 days.
SETTING: Research laboratory in a university medical center.
SUBJECTS: Twelve litters of 1-day-old Sprague-Dawley rat pups and nursing dams.
INTERVENTIONS: Hypoxia exposure, food restriction, GH administration.
MEASUREMENTS AND MAIN RESULTS: By the end of the study, body weights of the hypoxic and pair-fed pups were significantly lower than the weights of control animals (p < .001 for both groups), and weight gain correlated significantly with total dam food consumption (r2 = .85, p < .0001). GH administration increased weight gain only in hypoxic animals (p < .001) but it increased tail lengths significantly in both hypoxic and control pups (p < .001). Serum IGF-I levels in both hypoxic and pair-fed pups were significantly lower than in control animals. Serum IGF-binding protein-3 (IGFBP-3) was significantly lower in the hypoxic compared with the control animals. GH administration resulted in significant increases in serum levels of IGFBP-3 in both the control (p < .05) and the hypoxic (p < .01) pups compared with their vehicle-treated litter mates.
CONCLUSIONS: Exogenous GH attenuates growth impairment associated with hypoxia but not with food restriction, and these effects may be mediated in part by IGFBP-3.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548213     DOI: 10.1097/00003246-199910000-00028

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  Insulin-like growth factor in muscle growth and its potential abuse by athletes.

Authors:  G R Adams
Journal:  Br J Sports Med       Date:  2000-12       Impact factor: 13.800

2.  Transmission of cutaneous infections in athletes.

Authors:  B B Adams
Journal:  Br J Sports Med       Date:  2000-12       Impact factor: 13.800

3.  Growth hormone therapy during neonatal hypoxia in rats: body composition, bone mineral density, and insulin-like growth factor-1 expression.

Authors:  H Raff; E D Bruder; B Jankowski; M K Oaks; R J Colman
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

4.  Epidermal growth factor and parathyroid hormone-related peptide mRNA in the mammary gland and their concentrations in milk: effects of postpartum hypoxia in lactating rats.

Authors:  E D Bruder; J Van Hoof; J B Young; H Raff
Journal:  Horm Metab Res       Date:  2008-03-06       Impact factor: 2.936

Review 5.  Metabolic consequences of sleep-disordered breathing.

Authors:  Jonathan Jun; Vsevolod Y Polotsky
Journal:  ILAR J       Date:  2009

6.  A Translational Model of Incomplete Catch-Up Growth: Early-Life Hypoxia and the Effect of Physical Activity.

Authors:  Shlomit Radom-Aizik; Frank P Zaldivar; Dwight M Nance; Fadia Haddad; Dan M Cooper; Gregory R Adams
Journal:  Clin Transl Sci       Date:  2018-03-30       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.